产品封面图

EA.hy926

收藏
  • 询价
  • 2025年10月13日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 生长状态

      贴壁生长

    • 细胞形态

      内皮样

    • 库存

      大量

    • 运输方式

      冻存运输

    • 物种来源

    • 是否是肿瘤细胞

      0

    • 组织来源

      somatic cell hybrid

    • ATCC Number

      CRL-2922™

    Designations: EA.hy926
    Depositors:  CS Edgell
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: endothelial

    Source: Tissue: somatic cell hybrid
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Antigen Expression: Factor VIII-related antigen; Homo sapiens, expressed
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 10,11,12
    D13S317: 11
    D16S539: 11,12
    D5S818: 11
    D7S820: 8,9,10
    THO1: 6,8,9.3
    TPOX: 8,9
    vWA: 14,17
    Comments: The human umbilical vein cell line, EA.hy926, was established by fusing primary human umbilical vein cells with a thioguanine-resistant clone of A549 by exposure to polyethylene glycol (PEG). Hybrid clones were selected in HAT medium and screened for factor VIII-related antigen. EA.hy926 cells have been maintained for more than 100 population doublings (PDLs). Electron photomicrographs demonstrate cytoplasmic distribution of Weibel-Palade bodies and tissue-specific organelles, characteristics of differentiated endothelial cell functions such as angiogenesis, homeostasis/thrombosis, blood pressure and inflammation. [PubMed: 6407019] [PubMed: 2079463]
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with Ca++/Mg++ free Dulbecco's phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Transfer cell suspension to a centrifuge tube and spin at approximately 125 X g for 5 to 10 minutes. Discard supernatant.
    6. Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels. An inoculum of 2 X 10(3) to 3 X 10(3) viable cells/sq. cm is recommended.
    7. Incubate cultures at 37C. Subculture when cell concentration reaches between 8 X 10(4) and 1 X 10(5) cells/sq. cm.
      Interval: Twice a week
      Subcultivation Ratio: A subcultivation ratio of 1:6 to 1:10 is recommended
      Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete Growth medium, 95%; DMSO, 5%
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
    recommended serum:ATCC 30-2020
    0.25% (w/v) Trypsin - 0.53 mM EDTA in Hank' BSS (w/o Ca++, Mg++):ATCC 30-2101
    phosphate-buffered saline:ATCC 30-2200
    Cell culture tested DMSO:ATCC 4-X
    Erythrosin B vital stain solution:ATCC 30-2404
    Trypan Blue vital stain solution:ATCC 30-2402
    References: 92902: Edgell CJ, et al. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80: 3734-3737, 1983. PubMed: 6407019
    92903: Bauer J, et al. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J. Cell. Physiol. 153: 437-449, 1992. PubMed: 1280276
    92904: Edgell CJ, et al. Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell. Dev. Biol. 26: 1167-1172, 1990. PubMed: 2079463
    92905: Rieber AJ, et al. Extent of differentiated gene expression in the human endothelium-derived EA.hy926 cell line. Thromb. Haemostasis 69: 476-480, 1993. PubMed: 8322270

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    •   ESCO-1520 ESCO 温度探头EA701CA-4 EA701CA-4

        ESCO-1526 ESCO 刷子EA109E-1 刷子EA109E-1 ESCO-1525 ESCO 夹具EA500-100 夹具EA500-100 ESCO-1524 ESCO 超音厚度计EA706X-10 EA706X-10 ESCO-1523 ESCO 扳手EA614CE-13 EA614CE-13 ESCO-1522 ESCO 扳手EA616BB-13 EA616BB-13 ESCO-1521 ESCO 翘片修正器EA

    •   ESCO-2185 ESCO 特殊扎带EA475HB-2 EA475HB-2

        ESCO-20130001 ESCO 插座EA940CH-2 EA940CH-2 CP-1310090072 ESCO 胶锤EA575D-25 EA575D-25 CP-1310090071 ESCO 胶锤EA575VH-60 EA575VH-60 ESCO-1310 ESCC 加长改锥EA550AK EA550AK ESCO-10041 ESCO 丝维套装EA829B EA829B ESCO-10040 ESCO 板手EA613

    • EA玫瑰花环试验

      相关专题 原理 B淋巴细胞有表面Fc受体,以鸡红细胞作为指示细胞与相应的抗红细胞抗体形成EA,B淋巴细胞可以通过Fc受体与EA形成花环,以此计算B淋巴细胞的数目。Fc受体并非B细胞所特有,中性粒细胞、单核细胞及巨噬细胞表面均有这种受体,但这些细胞可以通过形态学加以区别。此方法简单,目前较常采用,以检测B淋巴细胞的百分率。 材料与试剂 基本同EAC花环试验,只是不需要补体。 操作方法 1.EA悬液的制备 取4%鸡红细胞

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1400
    上海盖宁生物科技有限公司
    2025年12月29日询价
    ¥1480
    上海酶研生物科技有限公司
    2026年01月15日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年01月30日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月15日询价
    ¥1200
    上海匹拓生物科技有限公司
    2026年01月21日询价
    EA.hy926
    询价